Volume 28, Number 9—September 2022
Research Letter
Correlation between Clinical and Wastewater SARS-CoV-2 Genomic Surveillance, Oregon, USA
Devrim Kaya, Rebecca Falender, Tyler Radniecki, Matthew Geniza, Paul Cieslak, Christine Kelly, Noah Lininger, and Melissa Sutton
Table
Correlation between estimated SARS-CoV-2 variant proportions detected in clinical specimens and wastewater samples, Oregon, USA, February 7, 2021–February 26, 2022*
| Variant | r | R2 | p value | No. (%) pairwise observations included in correlation |
|---|---|---|---|---|
| All | 0.97 | 0.94 | <0.0001 | 233 (100) |
| Alpha B.1.1.7† | 0.96 | 0.93 | <0.0001 | 48 (20.6) |
| Beta B.1.351 | 0.61 | 0.38 | 0.0003 | 30 (12.9) |
| Delta B.1.617.2‡ | 0.98 | 0.97 | <0.0001 | 55 (23.6) |
| Epsilon B.1.427/429 | 0.86 | 0.74 | <0.0001 | 44 (18.9) |
| Gamma P.1§ | 0.71 | 0.50 | <0.0001 | 44 (18.9) |
| Omicron B.1.1.529¶ | 0.97 | 0.93 | <0.0001 | 12 (5.2) |
*Sequence data for clinical samples were retrieved from GISAID (https://www.gisaid.org). r, Pearson correlation coefficient; R2, simple linear regression with a least-squares regression line to assess model fit. †B.1.1.7 includes all Q sublineages. ‡B.1.617.2 includes all AY sublineages. §P.1 includes all P.1 sublineages. ¶B.1.1.529 includes all BA sublineages.
Page created: July 11, 2022
Page updated: August 19, 2022
Page reviewed: August 19, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.